ロード中...
Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy
In recent years, there has been a plethora of attempts to discover biomarkers that are more reliable than α-fetoprotein for the early prediction and prognosis of hepatocellular carcinoma (HCC). Efforts have involved such fields as genomics, transcriptomics, epigenetics, microRNA, exosomes, proteomic...
保存先:
| 出版年: | Metabolites |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7074571/ https://ncbi.nlm.nih.gov/pubmed/32012846 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/metabo10020050 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|